Ashwagandha for perimenopause and menopause symptoms: what the evidence actually shows

Does ashwagandha actually help perimenopause symptoms?

Partly, and the picture has shifted faster than most supplement claims usually do. The National Center for Complementary and Integrative Health, the NIH's own review body for herbal evidence, still states plainly that there isn't enough evidence to determine whether ashwagandha helps menopause symptoms as a category. That's the honest baseline. But that assessment reflects the accumulated evidence up to a point in time, and several newer, placebo-controlled trials specifically in midlife and menopausal women have reported results since — which is why this is a herb where 'no evidence' and 'no longer true' can both be accurate depending on which year's review you're reading.

Ashwagandha (Withania somnifera) is classified as an adaptogen, a category of herbs studied for their effect on the body's stress-response system rather than on a single symptom. Its mechanism runs through the hypothalamic-pituitary-adrenal axis — the same signaling loop that governs cortisol release — which is a biologically plausible reason it might touch several perimenopause complaints (poor sleep, a wired-but-exhausted stress response, irritability) that don't share an obvious cause on paper but do share a stress-hormone thread.

What do the actual clinical trials show?

The most directly relevant trial randomized 60 women aged 45 to 55, all with a clinical menopause diagnosis and at least ten hot flash episodes a week, to either KSM-66 ashwagandha root extract (300 milligrams twice daily) or placebo for eight weeks. The ashwagandha group's hot flash frequency dropped by roughly 3.9 episodes a week versus about 0.6 in the placebo group, a statistically significant difference. It's worth being precise about who this trial enrolled: postmenopausal women with a formal diagnosis, not perimenopausal women specifically, and hormone therapy users were excluded. That's a meaningfully different population from someone still cycling irregularly, so the result is suggestive rather than a direct answer for perimenopause.

A separate 24-week trial in 123 postmenopausal women tested ashwagandha and shatavari, another Ayurvedic herb, alone and combined, at 250 and 500 milligram daily doses. The 500-milligram ashwagandha arm showed the largest improvement on a standard menopause quality-of-life scale, along with better vascular function readings and reduced markers of bone breakdown compared with placebo — an interesting secondary finding, though bone density itself takes years to shift and one trial's biomarker changes shouldn't be read as a bone-protection guarantee.

What about stress, cortisol, and sleep specifically?

This is where ashwagandha's evidence base is oldest and most consistent, even outside menopause-specific trials. Multiple randomized, placebo-controlled studies in stressed adults — not limited to midlife women — have found that standardized root extract measurably lowers serum cortisol and improves self-reported stress and anxiety scores relative to placebo. Sleep researchers have found a similar pattern: several trials report improved sleep quality and reduced time to fall asleep, generally more pronounced in people who started out with clinically meaningful insomnia rather than mild, occasional sleeplessness.

The honest caveat is the same one that applies to a lot of adaptogen research: much of this cortisol and sleep evidence comes from general stressed-adult populations rather than perimenopausal women specifically, so the extrapolation is reasonable rather than proven. If disrupted sleep is your main complaint, our perimenopause insomnia guide covers the fuller mechanism and the full range of options, not just this one herb.

What dose did the studies actually use?

There's no single official dose, since ashwagandha isn't regulated as a drug with an established therapeutic range. The trials with the clearest menopause-specific results used standardized root extract (most commonly the KSM-66 branded extract) at 300 milligrams twice daily, for a 600-milligram total, or 250 to 500 milligrams once daily in the longer trial. Stress and sleep research outside the menopause-specific trials has used a similar range, generally 250 to 600 milligrams a day of a standardized extract. Products vary widely in what they actually deliver — 'ashwagandha' on a label can mean root extract, leaf extract, or a whole-plant powder, and these are not interchangeable in potency or in what's actually been studied.

Is ashwagandha safe? Who should not take it

For most healthy adults, short-term use — generally studied up to three to six months — is reasonably well tolerated, with the most common downsides being drowsiness and mild stomach upset. But ashwagandha has a longer list of contraindications than most popular supplements, and several of them land squarely in the perimenopause demographic.

• Thyroid conditions: ashwagandha can raise thyroid hormone activity and has been linked to case reports of thyrotoxicosis; it can also interact with thyroid medication like levothyroxine, making it hard to tell whether a lab change reflects the herb or your underlying condition. This matters in perimenopause specifically, since thyroid disorders are common in this age group and easy to mistake for hormonal symptoms.
• Autoimmune disease: because ashwagandha affects immune signaling, it's generally not recommended for autoimmune conditions such as rheumatoid arthritis, lupus, or Hashimoto's thyroiditis, where the effect on disease activity isn't predictable.
• Pregnancy and breastfeeding: ashwagandha should be avoided in pregnancy, due to a theoretical risk of triggering uterine contractions, and there isn't enough safety data for breastfeeding either. Perimenopause doesn't rule out pregnancy — a real consideration worth a look at our guide to pregnancy risk during perimenopause if that's a live question for you.
• Sedatives and sleep or anxiety medication: ashwagandha's own calming effect can compound with benzodiazepines, sleep aids, or other central-nervous-system depressants.
• Immunosuppressants, diabetes medication, and blood pressure medication: ashwagandha may amplify the effect of drugs in each of these categories, which can push blood sugar or blood pressure lower than intended or work against a prescribed immunosuppressant.
• Scheduled surgery: it's generally recommended to stop ashwagandha at least two weeks before a planned surgery, since its effects on the central nervous system and blood sugar can complicate anesthesia.
• Liver conditions: rare but documented case reports of clinically apparent liver injury exist for ashwagandha, which is why anyone with existing liver disease should treat it as a genuine, if uncommon, risk rather than a footnote.

How does ashwagandha compare with other perimenopause supplements?

Ashwagandha's edge over many other trending supplements is that it actually has placebo-controlled human trials behind it, including some now conducted specifically in menopausal women — that puts it ahead of options where the evidence is largely theoretical or drawn from animal studies. It's still a different category of evidence than hormone therapy, which remains the best-studied and most effective treatment specifically for hot flashes and night sweats. If you're weighing ashwagandha against the wider supplement landscape rather than in isolation, our evidence-ranked list of perimenopause supplements and this broader supplements guide show where it sits next to magnesium, vitamin D, and other commonly recommended options.

How long before you'd notice anything?

The trials with positive results ran eight to twenty-four weeks, which is a more realistic window than the one- or two-week trial period many women give a new supplement before writing it off. The stress and sleep effects reported in shorter trials tended to build gradually rather than appear in the first few days. If you've taken a consistent dose of a standardized extract for a full two months with no noticeable change in stress, sleep, or hot flash frequency, that's a reasonable point to conclude it isn't your answer rather than push further.

What to check before you buy

• Look for a named, standardized extract (KSM-66 and Sensoril are the two most studied branded extracts) rather than a vague 'ashwagandha powder' with no extraction method or withanolide percentage listed.
• Root extract, not leaf or whole-plant, is what most of the human trials discussed here actually used — check the label specifies root.
• Third-party testing marks (USP Verified, NSF Certified, or similar) confirm independent lab verification of what's actually in the capsule.
• If a product is bundled into a 'menopause blend' with several other herbs, you lose the ability to know which ingredient is doing anything if you notice a change — a single-ingredient product is easier to evaluate honestly.